The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity

Benedikt Weber, Manuel Hora, Pamina Kazman, Christoph Göbl, Carlo Camilloni, Bernd Reif, Johannes Buchner

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The antibody light chain (LC) consists of two domains and is essential for antigen binding in mature immunoglobulins. The two domains are connected by a highly conserved linker that comprises the structurally important Arg108 residue. In antibody light chain (AL) amyloidosis, a severe protein amyloid disease, the LC and its N-terminal variable domain (VL) convert to fibrils deposited in the tissues causing organ failure. Understanding the factors shaping the architecture of the LC is important for basic science, biotechnology and for deciphering the principles that lead to fibril formation. In this study, we examined the structure and properties of LC variants with a mutated or extended linker. We show that under destabilizing conditions, the linker modulates the amyloidogenicity of the LC. The fibril formation propensity of LC linker variants and their susceptibility to proteolysis directly correlate implying an interplay between the two LC domains. Using NMR and residual dipolar coupling-based simulations, we found that the linker residue Arg108 is a key factor regulating the relative orientation of the VL and CL domains, keeping them in a bent and dense, but still flexible conformation. Thus, inter-domain contacts and the relative orientation of VL and CL to each other are of major importance for maintaining the structural integrity of the full-length LC.

Original languageEnglish
Pages (from-to)4925-4940
Number of pages16
JournalJournal of Molecular Biology
Volume430
Issue number24
DOIs
StatePublished - 7 Dec 2018

Keywords

  • amyloid
  • antibody folding
  • intramolecular interactions
  • light chain linker
  • protein stability

Fingerprint

Dive into the research topics of 'The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity'. Together they form a unique fingerprint.

Cite this